Slow and stable growth is the new mantra for the spine market as the industry enters a mature stage – a welcome change from the turbulence experienced over the past few years. This year’s North American Spine Society (NASS) conference in Chicago was more subdued than past meetings and not rocked by major M&A or IPO announcements or new blockbuster products. (SeeAlso see "Orthopedics: Bracing For Change" - Medtech Insight, 29 May, 2015..) Instead, the buzz centered around ancillary approaches to fusion – the industry’s largest segment accounting for 88% of the total US spine hardware market according to BioMedGPS’ SmartTRAK Financial Dashboard as shown in Exhibit 1. Patient-specific tools, robotics, biologics, expandable cages and, not surprisingly, minimally invasive surgery and cervical discs were the dominant themes of the meeting. The general consensus based on conversations on the NASS 2015 exhibit floor is that the $9 billion global spine market will expand at a slow pace (about 2%), pricing will remain under pressure and the pure-play spine companies (NuVasive Inc., Globus Medical Inc., K2M Group Holdings Inc. and [LDR Spine USA Inc.]/LDR Holding Corp.) will continue to grab share from the diversified giants. (SeeAlso see "Spine Market: Making A Comeback" - Medtech Insight, 30 January, 2015..)
Spine Market: Pure Plays Continue to Grab Share
Amidst low growth and a potential rebound in the $9 billion global spine market, the pure-play spine companies, including NuVasive, Globus, K2M and LDR, continue to outperform and grab share from the diversified giants. Medtech Insight founder and former CEO Sharon O'Reilly reports on these companies and more from the 2015 North American Spine Society (NASS) conference in Chicago, where the latest news centered around ancillary approaches to fusion, patient-specific tools, robotics, biologics, expandable cages, MIS and cervical discs.
More from Deals
Careology and Entia are partnering to “alleviate the burden of routine patient assessments” on people with cancer. The two early-stage London-based health tech startups already provide services to UK National Health Service (NHS) patients.
Zydus Lifesciences plans to expand global markets for patented products of French orthopedic tech company Amplitude Surgicals which it is acquiring from PE firm PAI Partners and others. Could the European business also serve as a buffer to upheaval in the US amid talks of tariffs?
A planned merger between medical device coating manufacturers Surmodics and Biocoat is facing an antitrust lawsuit from the US Federal Trade Commission. The FTC believes the move would create an illegal monopoly.
Boston Scientific has entered the multi-billion hypertension treatment market with the acquisition of Israel-based startup SoniVie, developer of the TIVUS intravascular ultrasound system for the treatment of high blood pressure by artery nerve ablation.
More from Business
Leann Sims joins AbundaBox as COO; Oura Ring firm appoints CMO.
Vektor Medical is ramping up efforts to bring its vMap technology used to identify arrhythmia sources to more US hospitals, start enrollment in a multinational trial, and commercialize in Europe, pending the CE mark. Medtech Insight sat down with CEO Rob Krummen at LSI 2025 to discuss their plans.
Only 16% of venture capital general partners in Europe are women, and only 9% of those have actual investment power. Thena Capital is aiming to "redefine the image of a venture capitalist."